Narrow search
Showing 1 - 2 of 2
Cover Image
Cost utility analysis of early adjuvant letrozole or anastrozole versus tamoxifen in postmenopausal women with early invasive breast cancer: the UK perspective
Karnon, Jonathan; Delea, Thomas; Barghout, Vicki - In: The European Journal of Health Economics 9 (2008) 2, pp. 171-183
Persistent link: https://www.econbiz.de/10005167133
Cover Image
Tamoxifen Plus Chemotherapy versus Tamoxifen Alone as Adjuvant Therapies for Node-Positive Postmenopausal Women with Early Breast Cancer: A Stochastic Economic Evaluation
Karnon, Jonathan; Brown, Jackie - In: PharmacoEconomics 20 (2002) 2, pp. 119-137
Background: There remains uncertainty around the appropriate choice of adjuvant therapies to offer postmenopausal women with node-positive early breast cancer. Objective and study design: To present the results derived from a discrete event simulation (DES) model that compared tamoxifen plus...
Persistent link: https://www.econbiz.de/10005590280